No, you cannot order methylphenidate with refills—it is a Schedule II controlled substance that requires a new written or electronic prescription for each fill.
Methylphenidate is classified as a Schedule II controlled substance under the Controlled Substances Act, which prohibits refills on prescriptions 1. This classification reflects its high potential for abuse, misuse, and development of substance use disorder, including addiction 1.
Key Regulatory Requirements
Prescription Rules for Schedule II Medications
- No refills are permitted on Schedule II controlled substances
- Each dispensing requires a new prescription (written or electronic)
- The prescription must be from a DEA-registered prescriber
- Most states now require prescriber participation in prescription drug monitoring programs 2
Clinical Implications for Practice
When prescribing methylphenidate, you must:
- Write a new prescription for each 30-day supply (or whatever duration you prescribe)
- Consider using electronic prescribing systems that comply with DEA requirements
- Monitor prescription refill requests for signs of misuse or diversion, particularly in adolescents 2
- Be aware that diversion (use for something other than intended medical purposes) is a special concern among adolescents 2
Alternative Strategies to Reduce Prescription Burden
While you cannot provide refills, you can:
- Prescribe up to a 90-day supply in a single prescription (where state law permits)
- Provide multiple separate prescriptions dated for future fills (check your state regulations, as some states allow this)
- Consider non-stimulant alternatives (atomoxetine, extended-release guanfacine, or extended-release clonidine) for patients at higher risk of diversion or when abuse potential is a concern 2
Important Safety Monitoring
The Schedule II classification also underscores the need for:
- Regular monitoring visits (guidelines recommend at least every 6 months, though adherence is often suboptimal) 3
- Assessment for signs of abuse, misuse, or diversion 1
- Cardiovascular monitoring (pulse rate, blood pressure) 4
- Growth monitoring in children and adolescents (height and weight at least annually) 2, 3
Common pitfall: Attempting to provide "refill" prescriptions by writing multiple prescriptions at once without proper dating and documentation can violate DEA regulations. Always ensure compliance with both federal DEA requirements and your state's specific controlled substance prescribing laws.